Parents of children affected by food anaphylaxis and/or autism have spent numerous years and countless hours investigating why our children are affected with such severe immune system and brain malfunctions. The PENTA Project investigations have revealed that the PENTA 5 in 1 combination (1994 – 1997) did not have a DIN # or a Notice of Compliance rendering it illegal according to Health Canada. 11,000+ adverse events, including deaths, were reported to PHAC for the PENTA combination over the three years that PENTA was in use. You may request PHAC ATIP reports A-2013-00096 and A-2013-00097 to view all of this data, which is too large to upload to a website. All subsequent 5 in 1 vaccines including Pentacel and Pediacel are based on this illegal combination, putting into question all vaccine schedules since 1994.
Access to Information requests over many years to all levels of government including requesting PENTA licensing information provided scant information, and Ontario, Canada, and local health unit ATIP responses did not acknowledge that the PENTA combination existed at all!
The Biologics and Genetic Therapies Directorate at Health Canada admits in this e-mail that “As a result the Penta vaccine does not have an associated DIN of its own” which renders it illegal in Canada.
A University of Saskatchewan information sheet (2004) stated, “Significant side effects were observed after PENTA vaccination, commonly blamed on the whole cell pertussis component. PENTA was also only about 60–80% effective against pertussis.”
Only one study for the PENTA combination was referenced by Canada’s National Advisory Committee on Immunization in their Supplementary statement on newly licensed Haemophilus influenzae type B (Hib) conjugate vaccines in combination with other vaccines recommended for infants. That study, Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age (pdf) was funded by the vaccine manufacturer, Connaught Laboratories Ltd. There are lots of concerns in this article. Infants were followed for 48 hours, but “Nurses were authorized to extend follow-up for 7 to 10 days by telephone or home visit if severe adverse events occurred.” 440 infants were enrolled, all receiving 5 vaccines in one injection or separate injections. It is terrifying to think that the following was considered as justification to give babies five vaccinations at once:
“Thirteen infants were withdrawn from the study: … “1 because of maternal request following adverse symptoms after dose 2; 1 because of physician request after unconsolable crying following dose 1; 1 because of developmental delay with onset unrelated temporally to vaccination ; and 3 after severe adverse events leading to hospitalization within 48 hours of vaccination.”
“Three severe adverse events temporally associated with vaccination resulted in hospitalization; (1) an infant (Group C2) developed supraventricular tachycardia 48 hours after Dose 1 which responded promptly to digoxin therapy; (2) an infant (Group S1) was hospitalized after waking 3 hours after Dose 1 with cough, respiratory distress and cyanosis. Recovery occurred within 4 hours. Aspiration or gastro-esophageal reflux was suspected; (3) an infant (Group S2) was hospitalized after an episode of screaming with apnea or breath-holding 4 hours after Dose 1.”
“The causes of the interactions among antigens in both the quadrivalent and pentavalent vaccines are not known. The hypothesis that the tetanus toxoid conjugate is involved in producing the interactions is supported by the lack of such interactions after vaccination with combined DPT H. influenzae-CRM conjugate (Hb)C vaccines.”
“The clinical relevance of the reduced antibody concentrations in relation to protection against disease is unknown.”
In Memory of Pierre Morin, Penta vaccine parent, who passed away in October, 2010.